ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.
Synonyms: IRS-1; Insulin Receptor Substrate 1
Storage: 2-8C
Application: Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected phospho-IRS1 (Tyr612) in lysate from NIH3T3 cells treated with Insulin.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected Insulin receptor substrate 1 in human breast cancer and human prostate cancer tissue sections.Peptide Inhibition Analysis: A 1:1,000 dilution from a representative lot was used with insulin treated HEK293 cells for phosphopeptide block analysis.
Legal Information: ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany